Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer

Stopped early · Phase 1

Conditions studied: Adult Spinal Cord Neoplasm, Spinal Bone Metastases, Spinal Cord Compression

In brief

This pilot clinical trial studies beta-tricalcium phosphate bone graft in treating patients undergoing surgery for metastatic spine cancer. A bone graft may help healing and bone growth in patients undergoing surgery for spine cancer

Key facts

Study ID

NCT01407341

Run by

University of Southern California

People needed

1

Starts

2011-06-01

Expected to finish

2012-08-01

Last updated by the study team

2014-02-06

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients undergoing surgery for spinal decompression for tatic spine cancer who require bone substitute for a posterolateral spinal fusion
• Patients may or may not have posterolateral instrumentation

You may not qualify if…

• Status-post previous fusion with allogeneic bone graft

Where it is running

• University of Southern California — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.